Lung cancer stem cells: a biological and clinical perspective Ana KorenHelena MotalnTanja Cufer Review 31 July 2013 Pages: 265 - 275
Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer Nir PeledMurry W. WynesFred R. Hirsch Original Paper 26 April 2013 Pages: 277 - 288
In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation Macarena PeránJuan Antonio MarchalDavid Tosh Original Paper 16 May 2013 Pages: 289 - 301
Biofunctional characteristics of in situ and invasive breast carcinoma Sara BravacciniAnna Maria GranatoDino Amadori Original Paper 27 June 2013 Pages: 303 - 310
Over-expression of Her-2 in colorectal cancer tissue, but not in serum, constitutes an independent worse prognostic factor Sang-Woo LimHye-Ran KimMyung-Geun Shin Original Paper 31 May 2013 Pages: 311 - 321
Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas Yanjie YouWenjun YangYonggang Ran Original Paper 06 June 2013 Pages: 323 - 331
Analysis of expression of membrane-bound tumor markers in ductal carcinoma in situ of the breast: paving the way for molecular imaging Jeroen F. VermeulenElsken van der WallPaul J. van Diest OriginalPaper 07 June 2013 Pages: 333 - 340
Visualising and quantifying angiogenesis in metastatic colorectal cancer Torben Frøstrup HansenBoye Schnack NielsenFlemming Brandt Sørensen Original Paper 10 July 2013 Pages: 341 - 350